- Home
- OCFT vs GOSS Comparison
OCFT vs GOSS Comparison
Compare OCFT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- GOSS
- Stock Information
- Founded
- OCFT 2015
- GOSS 2015
- Country
- OCFT China
- GOSS United States
- Employees
- OCFT N/A
- GOSS N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- OCFT Technology
- GOSS Health Care
- Exchange
- OCFT Nasdaq
- GOSS Nasdaq
- Market Cap
- OCFT 169.6M
- GOSS 188.6M
- IPO Year
- OCFT 2019
- GOSS 2019
- Fundamental
- Price
- OCFT $6.07
- GOSS $0.84
- Analyst Decision
- OCFT
- GOSS Strong Buy
- Analyst Count
- OCFT 0
- GOSS 4
- Target Price
- OCFT N/A
- GOSS $7.50
- AVG Volume (30 Days)
- OCFT 77.6K
- GOSS 1.5M
- Earning Date
- OCFT 05-20-2025
- GOSS 05-06-2025
- Dividend Yield
- OCFT N/A
- GOSS N/A
- EPS Growth
- OCFT N/A
- GOSS N/A
- EPS
- OCFT N/A
- GOSS N/A
- Revenue
- OCFT $307,997,287.00
- GOSS $114,701,000.00
- Revenue This Year
- OCFT N/A
- GOSS N/A
- Revenue Next Year
- OCFT $6.37
- GOSS $172.31
- P/E Ratio
- OCFT N/A
- GOSS N/A
- Revenue Growth
- OCFT N/A
- GOSS N/A
- 52 Week Low
- OCFT $0.87
- GOSS $0.50
- 52 Week High
- OCFT $6.90
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- OCFT 49.29
- GOSS 37.58
- Support Level
- OCFT $5.40
- GOSS $0.80
- Resistance Level
- OCFT $6.45
- GOSS $0.88
- Average True Range (ATR)
- OCFT 0.33
- GOSS 0.10
- MACD
- OCFT -0.10
- GOSS -0.01
- Stochastic Oscillator
- OCFT 47.86
- GOSS 20.24
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.